← All companies

CLYD

BEACON TOPCO, INC.

CLYD Pharmaceutical Preparations EDGAR ↗

—

—

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$0.00

Total assets

$0.00

Gross margin

—

52-week range

—

Recent SEC filings

10 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 14, 2026 10-Q Quarter ended 2026-03-31 Jun 5, 2026

Other filings

SP 15D2 Jul 2, 2026 424B3 Apr 23, 2026 EFFECT Apr 22, 2026 S-4/A Apr 13, 2026 S-4/A Mar 31, 2026 S-4/A Mar 13, 2026 S-4/A Jan 27, 2026 S-4 Nov 7, 2025